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ABSTRACT 
Objectives: To evaluate the effect of concurrent pelvic organ prolapse (POP) reconstructive surgery on midurethral sling 
(MUS) procedure outcome. 
Material and methods: The present retrospective study included 300 women with urodynamically diagnosed stress 
urinary incontinence that underwent MUS procedures with or without concurrent POP reconstructive surgery. Patients 
were divided into four groups according to the performed surgery; 1) transobturator tape (TOT), 2) TOT with POP surgery 
(anterior colporrhaphy, posterior colporrhaphy and vaginal hysterectomy), 3) tension free vaginal tape (TVT), 4) TVT with 
POP surgery. Outcomes of surgeries for each group were evaluated postoperatively at the end of the first and sixth month 
by performing a cough stress test and also using the Incontinence Impact Questionnaire-7 (IIQ-7) and Urogenital Distress 
Inventory (UDI-6) questionnaires. Presence of a negative cough stress test was defined as “Cure”. Multivariate regression 
was used to identify the parameters for surgical failure.
Results: Forty-two, 70, 49 and 139 women underwent isolated TOT, concurrent TOT and POP, isolated TVT and concurrent 
TVT and POP surgery, respectively. Postoperative UDI-6 score and postoperative cure rate were significantly higher in the 
only TOT group as compared to the TOT + POP group. However, in multiple regression analysis, women’s age, parity, body 
mass index, menopausal status, preoperative urodynamic parameters, MUS types and presence of any concomitant POP 
reconstructive surgery were found to have no significant effect on surgical outcome. 
Conclusions: Concurrent POP reconstructive surgery including anterior colporrhaphy, posterior colporrhaphy and vaginal 
hysterectomy have no affect MUS procedure outcomes.
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INTRODUCTION 
The International Continence Society (ICS) defines urina-
ry incontinence (UI) as “the condition in which the involun-
tary loss of urine is objectively demonstrable and is a social 
or hygiene problem” [1]. UI is a public health issue, costing 
approximately 12.43 billion dollars per year in the US [2]. 
Stress urinary incontinence (SUI) is defined as the com-
plaint of involuntary leakage of urine upon effort or exertion, 
or on sneezing or coughing [3, 4]. Although SUI, the most 
common type of UI, may seen in women of all age groups, 
its incidence steady elevates in later life. The incidence of 
SUI increases from 2.5% in nulliparous women to 30% in 
menopausal women [5, 6].
Pelvic Organ Prolapse (POP) is described as the descen-
ding or sagging of the anterior, posterior or top portion 
(vaginal vault/cervix) of the vagina, solely or all together. The 
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most common etiology includes vaginal birth followed by 
trauma (chronic constipation, obesity, etc.) increasing the 
intraabdominal pressure [7]. Although the incidence of POP 
is not known, around 11% of women in the US require sur-
gery due to prolapse or incontinence and more than 1/3 of 
those need reoperation [8].
Since they share similar underlying reasons, urinary 
and anal incontinence, pelvic organ prolapse and sexu-
al dysfunction may appear together due to loss of pelvic 
support [9]. 
Many vaginal and abdominal surgical techniques have 
been developed for cases of SUI requiring surgical treat-
ment. The most preferred surgical technique is the tension-
-free vaginal tape (TVT) procedure developed by Ulmsten 
in 1996 [10]. Various methods have been developed to re-
duce the complications of this operation, among which 
we can mention the transobturator tape (TOT) technique 
developed by Delorme in 2001 [11].
The principal purpose of this intervention is to restore 
normal function by correcting the impaired anatomy. Since 
it is thought to share a similar underlying mechanism, cur-
rently routine incontinence techniques are proposed to be 
integrated with prolapse repair [12]. Therefore, the influence 
of POP repair concomitant with incontinence surgery should 
be evaluated.
OBJECTIVES
 In this study, we aimed to evaluate the impact of con-
current POP reconstructive surgery (anterior colporrhaphy, 
posterior colporrhaphy or vaginal hysterectomy) on MUS 
procedure outcomes in TVT and TOT subgroups.
MATERIAL AND METHODS
A total of 300 patients diagnosed with SUI and who un-
derwent mid-urethral sling (TOT or TVT operation) surgery 
between May 2012 and February 2015 at the Ankara Zekai 
Tahir Burak Women’s Health Care Education and Research 
Hospital, Urogynecology Outpatient Clinic were included 
in this study. 
The study was approved by the local ethics committee 
of the hospital. Demographic characteristics were noted 
from patients’ files. Patients with a systemic disease (HT, 
DM, neurologic disorder, etc.) and those without complete 
follow-up data were excluded from the study. Preoperative 
urogynecologic examinations included the Baden-Walker 
Halfway Scoring System for the assessment of POP [13]. 
The study population was divided into four groups; 
Group 1, patients who underwent TOT surgery; Group 2, 
patients who underwent TOT + POP surgery; Group 3, pa-
tients who underwent TVT surgery; and Group 4, patients 
who underwent TVT + POP surgery. 
Preoperative urodynamic examination was performed 
to all patients based on the ICS criteria [7]. Before this exa-
mination, complete urinary test and urine cultures were ob-
tained to exclude urinary infection. TOT and TVT operations 
were performed by the same operating team using general 
or regional anesthesia (O.A, M.D, B.C). The TOT and TVT tech-
nique was performed considering Delorme’s description 
for the outside-in approach [12] and Ulmsten’s for the insi-
de-out technique [10], respectively. Type-1 monofilament 
polypropylene mesh was used for both operations. More-
over, concomitant operations for POP reconstruction and 
intraoperative complications were noted. Patient records 
were retrospectively reviewed to determine preoperative, 
postoperative 1st month and postoperative 6th month sa-
tisfaction levels using the Incontinence Impact Questionna-
ire-7 (IIQ-7) and Urogenital Distress Inventory (UDI-6) survey 
forms validated for the Turkish language [14]. Negative and 
positive postoperative stress test was considered as “cure” 
and “failure”, respectively.
Statistical analyses were carried out using SPSS version 
22.0 (IBM SPSS, Chicago, IL). Abnormal distribution of the 
study data required use of independent sample t-test for 
paired comparison and the study data were expressed as 
mean ± standard deviation values. Categorical data were 
compared with Pearson’s chi-square test and the results 
were expressed as number (n) and percentage (%). A binary 
logistic regression model was employed to investigate pa-
rameters affecting the cure rate and Odd’s ratio was calcu-
lated and evaluated. P < 0.05 was recognized as statistically 
significant. 
RESULTS
A total of 300 patients were eligible for the study ac-
cording to our inclusion criteria. The TOT procedure was 
performed in 112 patients; 42 women without POP and 
70 women with POP surgery including colporrhaphy (an-
terior and/or posterior) (n = 44), and colporrhaphy and 
concomitant vaginal hysterectomy (VAH) (n = 26). Of the 
188 patients who underwent TVT and 49 of those without 
POP. The remaining 139 women underwent TOT with POP 
surgery including colporrrhaphy (anterior and/or posterior) 
(n = 106) and colporhaphy and concomitant VAH (n = 33). 
The demographic characteristics of the groups were 
shown in Table 1. Table 2 shows the intergroup comparison 
of preoperative, postoperative 1st and 6th month IIQ7 and 
preoperative, postoperative 1st and 6th month IDU6, and 
also postoperative 1st and 6th month cure rates. The po-
stoperative 1st month cure rate was significantly higher 
in Group 1 (90.5%) than in Group 2 (76.0%) (P = 0.04). Si-
milarly, Group 4 (88.0%) had a significantly higher cure 
rate compared to Group 2 (76.0%) (P = 0.02). There was no 
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Table 1. Demographic characteristics of the groups
TOT (n = 112) TVT (n = 188)
POP (–)
 (n = 42)
 (I)
POP (+)
 (n = 70)
 (II)
P1
POP (–)
 (n = 49) 
 (III)
POP (+)
 (n = 139)
 (IV)
P2 P3 P4
Age (years) 52.0 ± 9.2 55.0 ± 9.5 0.05 49.0 ± 9.0 50.0 ± 8.0 0.90 0.20 0.00
Vaginal birth (n) 2.6 ± 1.4 3.9 ± 2.3 0.01 2.6 ± 1.4 3.1 ± 1.3 0.10 0.70 0.07
BMI (kg/m2) 29.0 ± 4.7 29.0 ± 4.7 0.80 30.0 ± 4.1 30.0 ± 4.0 0.40 0.50 0.60
Menopausal status 21 (50.0) 48 (68.6) 0.05 13 (26.5) 50 (36.0) 0.10 0.01 0.00
Smoking 10 (23.8) 6 (8.6) 0.02 7 (14.3) 26 (18.7) 0.30 0.10 0.03
History of macrosomic birth 8 (19.0) 7 (10.0) 0.10 8 (16.3) 27 (19.4) 0.40 0.40 0.05
≥ Grade cystocele 19 (45.2) 66 (94.3) 0.00 21 (42.9) 113 (81.3) 0.00 0.60 0.01
≥ Grade 2 rectocele 15 (35.7) 55 (78.6) 0.00 16 (32.7) 97 (69.8) 0.00 0.50 0.20
≥ Grade 2 descensus 0 (0.0) 26 (37.1) 0.00 0 (0.0) 31 (22.3) 0.00 0.50 0.10
MUCP 76.4 ± 31.0 69.1 ± 22.0 0.10 72.0 ± 53.0 65.0 ± 22.0 0.20 0.60 0.20
VLPP 75.0 ± 36.0 81.0 ± 37.0 0.40 74.0 ± 37.0 78.0 ± 41.0 0.50 0.80 0.50
Age, vaginal birth, BMI (body mass index), MUCP (Maximum Urethral Closure Pressure) and VLPP (Valsalva Leak Point Pressure) data are shown as mean ± standard 
deviation 
Menopausal status, smoking, macrosomic birth, cystocele, rectocele and descensus data are shown as n (%) 
P values were calculated by Independent sample t-test and Pearson’s chi square test 
P1 — probability value between Only TOT and TOT + POP groups 
P2 — probability value between Only TVT and TVT + POP groups 
P3 — probability value between Only TOT and Only TVT groups 
P4 — probability value between TOT +POP and TVT + POP groups 
P < 0.05 was considered statistically significant
Table 2. Intergroup comparison of postoperative cure rates
TOT (n = 112) TVT (n = 188)
POP (–)
 (n = 42)
POP (+)
 (n = 70) P1
POP (–)
 (n = 49)
POP (+)
 (n = 139) P2 P3 P4
IIQ7 (preoperative) 15.0 ± 4.9 14.0 ± 4.7 0.90 15.8 ± 3.9 14.9 ± 4.7 0.20 0.30 0.90
IDU6 (preoperative) 13.0 ± 3.0 13.0 ± 3.9 0.20 12.4 ± 4.3 12.8 ± 3.4 0.40 0.07 0.60
IIQ7 (at the end of the 1st month ) 3.9 ± 3.1 3.1 ± 2.2 0.10 2.9 ± 2.6 2.8 ± 2.7 0.80 0.10 0.50
IDU6 (at the end of the 1st month ) 3.4 ± 2.8 2.5 ± 1.7 0.04 2.6 ± 2,1 2.9 ± 2.5 0.40 0.10 0.30
Cure Rates (at the end of the 1st month ) 90.5 76.0 0.04 92.0 88.0 0.60 0.50 0.02
IIQ7 (at the end of the 6th month ) 2.9 ± 2.1 2.9 ± 2.6 0.95 2.9 ± 2.6 2.9 ± 2.7 0.87 0.11 0.51
IDU6 (at the end of the 6th month ) 2.6 ± 1.9 2.7 ± 2.3 0.68 2.6 ± 2.1 2.9 ± 2.6 0.45 0.11 0.31
Cure Rates (at the end of the 6th month ) 85.7 74.2 0.08 87.7 84.1 0.81 0.77 0.11
UDI6 — Urogenital Distress Inventory 6; IIQ7 — Incontinence Impact Questionnaire 7 
Data are shown as mean ± standard deviation 
Cure rates are shown as % 
P values were calculated by Independent sample t-test and Pearson’s chi square test 
P1 — probability value between Only TOT and TOT + POP groups 
P2 — probability value between Only TVT and TVT + POP groups 
P3 — probability value between Only TOT and Only TVT groups 
P4 — probability value between TOT + POP and TVT + POP groups 
P < 0.05 was considered statistically significant
statistically significant difference between the groups in 
terms of postoperative 6th month cure rate. There was also 
no significant intergroup difference with regard to preope-
rative IIQ7, postoperative IIQ7, and preoperative IDU6. Only 
postoperative IUD6 scores were significantly higher in Group 
1 than in Group 2 (P = 0.04). 
Intergroup comparison of the complication rates is 
shown in Table 3. A total of 29 (9.6%) patients developed 
complications. There was no statistically significant diffe-
rence between the groups in terms of complication rate 
(P = 0.35). The complications were de novo urge incontinen-
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ce in 7, mesh erosion in 2, hematoma in 1, bladder damage in 
8, hemorrhage in 10, and postoperative urinary dysfunction 
in 11 patients. No statistically significant difference was de-
termined between the groups in terms of complication rate.
Table 4 shows the logistic regression model of inde-
pendent factors that may affect the cure at the end of the 
1st month. The analysis showed that age, BMI, parity, me-
nopausal status, smoking status, history of macrosomia, 
preoperative MUCP (Maximum Urethral Closure Pressure), 
preoperative VLPP (Valsalva Leak Point Pressure), TVT-TOT 
preference, and presence of anterior colporrhaphy, posterior 
colporrhaphy and vaginal hysterectomy separately had no 
effect on cure rate. The same logistic regression analysis 
for the 6th month cure is shown in Table 5. Similarly, these 
independent factors such as age, BMI, parity, menopausal 
status, smoking status, history of macrosomia, preoperative 
MUCP, preoperative VLPP, TVT-TOT preference and inclusion 
of anterior colporrhaphy, posterior colporrhaphy and vagi-
nal hysterectomy individually had no effect on cure rate at 
the end of the 6th month.
DISCUSSION
In our study, concomitant POP reconstructive surgery 
accompanying MUS operation was found to have no effect 
on the success of incontinence treatment for short term 
results. Similarly, neither type of MUS nor presence of POP 
Surgery was found to have a significant effect on surgical 
success. 
In literature, there is limited data regarding the effect of 
concomitant POP repair on MUS outcome. In a study con-
ducted by Naidu et al., the patients were categorized into 
two groups as MUS and MUS + POP surgery groups. A sub-
Table 3. Intergroup comparison of complications
TOT TOT + POP TVT TVT + POP P value
Complications (+) 2 (4,8) 9 (12.9) 8 (16.3) 20 (14.4) 0.35
De novo urge 2 (4,8) 0 (0.0) 3 (6.1) 2 (1.4) 0.09
Mesh erosion 0 (0.0) 1 (1.4) 0 (0.0) 1 (0.7) 0.74
Hematoma 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.7) 0.76
Bladder injury 0 (0.0) 2 (2.9) 2 (4.1) 4 (2.9) 0.66
Bleeding 0 (0.0) 4 (5.7) 1 (2.0) 5 (3.6) 0.39
Urinary dysfunction 0 (0.0) 2 (2.9) 2 (4.1) 7 (5.0) 0.47
P values were calculated by Pearson’s chi square test 
Complication data are shown as n and (%) 
P < 0.05 was considered statistically significant
Table 4. Regression analysis of variables that may influence MUS outcomes at the end of the 1st month
Variable Number (n/n) Wald
Exp
 (B) P
95% CI  
for Exp
 (B)
Age (60 y </≥ 60 y) 61/239 0.29 0.77 0.59 0.29–1.98
TOT / TVT 112/188 3.80 0.50 0.06 0.24–1.00
Anterior colporrhaphy (±) 179/121 0.34 1.31 0.56 0.52–3.23
Posterior colporrhaphy (±) 152/148 1.28 0.62 0.26 0.27–1.42
Vaginal hysterectomy (±) 57/243 0.01 0.96 0.93 0.37–2.45
Body mass index (30 </≥ 30) (kg/m2) 148/152 0.03 1.06 0.86 0.53–2.12
Parity (n) — 0.13 0.90 0.73 0.51–3.21
Menopausal status (±) 132/168 0.99 0.67 0.32 0.29–1.48
Smoking (±) 49/251 0.55 0.68 0.46 0.24–1.88
Macrosomic birth (±) 50/250 0.04 0.91 0.85 0.35–2.35
MUCP (40 </≥ 40) 271/29 0.05 0.88 0.83 0.281–2.76
VLPP (90 </≥ 90) 104/196 0.92 1.40 0.34 0.70–2.80
MUCP — Maximum Urethral Closure Pressure; VLPP — Valsalva Leak Point Pressure 
Values were calculated by Binary Logistic Regression Model 
P < 0.05 was considered statistically significant
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jective cure was achieved for SUI in 65% of the MUS group 
and in 53% of the MUS + POP treatment group. There was 
no significance difference considering cure rate among 
groups [15]. In 2015, Law et al. evaluated the efficacy and 
outcome of concomitant POP repair during urinary incon-
tinence surgery by comparing 218 women who underwent 
TOT-TVT operation due to SUI [16]. The patients were split 
into two groups as the TOT-TVT group and the concomitant 
prolapse repair (anterior/posterior and/or colporrhaphy 
and/or vaginal hysterectomy) group. Although the study 
population underwent two different incontinence surgery 
(TOT, (n = 124) and TVT, (n = 94)), the authors considered 
as one group regarding similar efficiency of TOT and TVT. 
TOT-TVT and concomitant pelvic floor repair groups showed 
no difference in terms of complications, urinary dysfunction, 
vaginal erosion, and persistent pelvic pain symptoms. The 
study found concomitant application of pelvic organ pro-
lapse repair during TOT-TVT to be a reliable and effective 
treatment for SUI. In our study, the complete cure rates for 
SUI symptoms were 90.5% and 85.7% in the isolated TOT 
group, 76% and 74% in the TOT + POP group, 92% and 88% 
in the TVT group, 88% and 84% in the TVT + POP group for 
the 1st month and 6th month after surgery, respectively. Our 
success rate was relatively higher compared to Naidu et al. 
and Law et al. This may be associated with better patient 
selection, use of proper method, and experienced staff. 
Additionally, we found that concomitant POP repair during 
MUS surgery did not have any influence on success rate 
which was consistent with result of previous studies [15, 16]. 
Our study had some strengthens including the individual 
assessment of TOT and TVT groups in terms of concomitant 
surgery and their short term results. 
In the literature, the incidence of complications in SUİ 
operations was reported with a wide range (0.3% to 43.0%) 
[17–22]. In the present study, the complications included in 
descending order of frequency bladder perforation (2.6%), 
de novo urgency (2.3%), mesh erosion (0.6%) and pelvic he-
matoma (0.3%). We observed relatively lower complication 
rate than previous study, probably associated with good 
patient selection and fine tape fitting, and attentive applica-
tion of the surgical technique. Naidu et al. reported the rate 
of bladder perforation (1% vs 1.1%), mesh erosion (1.5% vs 
1.1%), and retropubic hematoma (0.5% vs 2.2%) in isolated 
SUI and concurrent SUI and POP surgery, respectively [15]. 
These results were consistent with our study. 
Relatively adequate number of patients, homogeneous pa-
tient distribution and use of objective parameters for surgical 
cure such as quality of life questionnaires were the strengthens 
of our study. We also assessed the success of concomitant MUS 
and POP surgery in individual TVT and TOT subgroups. 
CONCLUSIONS
Performing POP reconstructive surgery during MUS 
operation was found to be a reliable procedure without 
complications, while having no impact on the success rate 
of MUS. However, future prospective studies including larger 
study populations are required to further verify our results. 
Acknowledgments 
None. 
Table 5. Regression analysis of variables that may influence MUS outcomes at the end of the 6th month
Variable Number (n/n) Wald
Exp
 (B) P 95% CI for Exp (B)
Age (60 y </≥ 60 y) 61/239 0.24 0.81 0.63 0.33-1.93
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